Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples